工程肝脏特异性促进剂:在基因治疗中的设计,机制和临床应用的全面审查
Valentin Artemyev1, Anastasiia Iu Paremskaia2, Amina A Dzhioeva1
1Moscow Center for Advanced Studies, Kulakova Str. 20, Moscow 123592, Russia.
Cells
|January 9, 2026
概括
肝脏特异性促进剂对于有效的基因疗法至关重要,其向肝脏,这是一个关键的代谢器官. 本综述分析了促进体设计和用于治疗遗传疾病的应用.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因治疗 基因治疗
- 分子生物学分子生物学
背景情况:
- 肝脏是中央代谢器官,也是基因疗法的首要目标,因为它具有分泌能力,代谢调节和免疫耐受性.
- 以肝脏为导向的基因疗法为各种遗传代谢障碍和凝血因子缺陷提供了潜在的治疗方法.
研究的目的:
- 综合审查用于基因治疗的肝脏特异性促进剂的设计,工程和应用.
- 讨论肝脏基因表达调节的基本原理.
- 要突出使肝脏成为基因疗法的理想目标的生理和免疫特征.
主要方法:
- 关于肝脏特异性促进剂的临床前和临床研究的文献综述.
- 分析促销商设计策略,包括合成促销商.
- 对基因表达调节和肝脏生理学的讨论.
主要成果:
- 许多肝脏特异性促进剂已被用于基因治疗研究,并正在开发新的合成选择.
- 了解基因表达调节和肝脏特征对于成功的基因治疗至关重要.
- 促进者选择直接影响肝脏导向基因疗法的疗效和安全性.
结论:
- 肝脏特异性促进剂对于针对代谢性和遗传性肝脏疾病的基因治疗的成功至关重要.
- 对促进体设计和肝脏生物学的持续研究将推动基因疗法应用.
- 肝脏的独特特性使其成为一种非常适合用于治疗性基因传递的器官.
更多相关视频
09:13Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
Published on: October 24, 2016
8.5K
09:54Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
8.5K
相关概念视频
00:59Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
01:29Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928